Zhende Medical (China) Performance
| 603301 Stock | 20.37 0.22 1.07% |
The firm maintains a market beta of 0.0724, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Zhende Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zhende Medical is expected to be smaller as well. At this point, Zhende Medical has a negative expected return of -0.13%. Please make sure to check out Zhende Medical's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Zhende Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Zhende Medical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Payout Ratio 1.6447 | Last Split Factor 1.4:1 | Ex Dividend Date 2024-07-03 | Last Split Date 2020-06-08 |
1 | Vimian Group Among 3 Stocks Estimated To Be Trading Below Their Intrinsic Value - Simply Wall St | 01/08/2025 |
| Begin Period Cash Flow | 2.1 B |
Zhende |
Zhende Medical Relative Risk vs. Return Landscape
If you would invest 2,227 in Zhende Medical Co on October 13, 2024 and sell it today you would lose (190.00) from holding Zhende Medical Co or give up 8.53% of portfolio value over 90 days. Zhende Medical Co is generating negative expected returns and assumes 1.3514% volatility on return distribution over the 90 days horizon. Simply put, 12% of stocks are less volatile than Zhende, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Zhende Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zhende Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zhende Medical Co, and traders can use it to determine the average amount a Zhende Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0963
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 603301 |
Estimated Market Risk
| 1.35 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Zhende Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zhende Medical by adding Zhende Medical to a well-diversified portfolio.
Zhende Medical Fundamentals Growth
Zhende Stock prices reflect investors' perceptions of the future prospects and financial health of Zhende Medical, and Zhende Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zhende Stock performance.
| Return On Equity | 0.0385 | ||||
| Return On Asset | 0.0156 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 5.35 B | ||||
| Shares Outstanding | 266.45 M | ||||
| Price To Book | 0.98 X | ||||
| Price To Sales | 1.35 X | ||||
| Revenue | 4.13 B | ||||
| Gross Profit | 1.74 B | ||||
| EBITDA | 462.31 M | ||||
| Net Income | 198.4 M | ||||
| Total Debt | 220.14 M | ||||
| Book Value Per Share | 20.96 X | ||||
| Cash Flow From Operations | 452.11 M | ||||
| Earnings Per Share | 0.76 X | ||||
| Total Asset | 7.27 B | ||||
| Retained Earnings | 3.14 B | ||||
About Zhende Medical Performance
By analyzing Zhende Medical's fundamental ratios, stakeholders can gain valuable insights into Zhende Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zhende Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zhende Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Zhende Medical is entity of China. It is traded as Stock on SHG exchange.Things to note about Zhende Medical performance evaluation
Checking the ongoing alerts about Zhende Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zhende Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zhende Medical generated a negative expected return over the last 90 days | |
| Zhende Medical is unlikely to experience financial distress in the next 2 years | |
| About 61.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Vimian Group Among 3 Stocks Estimated To Be Trading Below Their Intrinsic Value - Simply Wall St |
- Analyzing Zhende Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zhende Medical's stock is overvalued or undervalued compared to its peers.
- Examining Zhende Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zhende Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zhende Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zhende Medical's stock. These opinions can provide insight into Zhende Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Zhende Stock analysis
When running Zhende Medical's price analysis, check to measure Zhende Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhende Medical is operating at the current time. Most of Zhende Medical's value examination focuses on studying past and present price action to predict the probability of Zhende Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhende Medical's price. Additionally, you may evaluate how the addition of Zhende Medical to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |